WINNERS & LOSERS: Pinewood and Pharos back takeover offers
27th Jul 2026 10:23
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 1.25p on 24-08-2026 at 18:15:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 1.30p |
| Sell | 1.20p |
| Last Trade: | Sell 6,557.00 at 1.2285p |
| Day's Volume: | 792,968 |
| Last Close: | 1.25p |
| Open: | 1.25p |
| ISIN: | GB00BFPMV798 |
| Day's Range | 1.25p - 1.25p |
| 52wk Range: | 0.35p - 1.65p |
| Market Capitalisation: | £11.94m |
| VWAP: | 1.254471p |
| Shares in Issue: | 955.54m |
Sector: Brokerage Services
Listed In: FTSE AIM All-Share,
Tern (TERN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 6,557 | 1.2285p | Ordinary |
16:14:36 - 24-Aug-26 |
| Sell* | 25,000 | 1.2285p | Ordinary |
15:11:36 - 24-Aug-26 |
| Buy* | 3,073 | 1.2688p | Ordinary |
13:50:34 - 24-Aug-26 |
| Buy* | 35,466 | 1.2688p | Ordinary |
13:45:26 - 24-Aug-26 |
| Buy* | 393,701 | 1.27p | Ordinary |
12:25:10 - 24-Aug-26 |
| Buy* | 78,740 | 1.27p | Ordinary |
12:21:51 - 24-Aug-26 |
| Sell* | 85,671 | 1.226p | Ordinary |
10:32:12 - 24-Aug-26 |
| Buy* | 230 | 1.30p | SI Trade |
10:14:20 - 24-Aug-26 |
| Sell* | 200 | 1.20p | SI Trade |
10:14:20 - 24-Aug-26 |
| Buy* | 769 | 1.30p | SI Trade |
10:14:20 - 24-Aug-26 |
Tern (TERN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Aug 2026 7:00 am | RNS | Loan Repayment |
| 31st Jul 2026 5:00 pm | RNS | Total Voting Rights |
| 28th Jul 2026 7:00 am | RNS | Talking Medicines CLN & Distribution Commitment |
| 15th Jul 2026 7:00 am | RNS | Placing to raise £450,000 & total voting rights |
| 9th Jul 2026 9:42 am | RNS | Result of GM |
| 30th Jun 2026 10:49 am | RNS | Result of AGM |
| 23rd Jun 2026 7:00 am | RNS | Results for the year ended 31 December 2025 |
| 8th Jun 2026 7:00 am | RNS | Notice of AGM |
| 29th May 2026 5:00 pm | RNS | Total Voting Rights |
| 26th May 2026 7:00 am | RNS | Investment in Talking Medicines CLNs |